A NOVEL MONOCLONAL ANTIBODY DEGRADES THE THYROTROPIN RECEPTOR AUTOANTIBODIES IN GRAVES' DISEASE.

[1]  P. D. Olivo.  Bioassays for thyrotropin receptor autoantibodies. , 2023, Best practice & research. Clinical endocrinology & metabolism.

[2]  Shuyang Zhang,et al.  Hormone- and antibody-mediated activation of the thyrotropin receptor , 2022, Nature.

[3]  R. Dror,et al.  Autoantibody mimicry of hormone action at the thyrotropin receptor , 2022, Nature.

[4]  P. D. Olivo,et al.  A rapid homogenous bioassay for detection of thyroid-stimulating antibodies based on a luminescent cyclic AMP biosensor. , 2021, Journal of immunological methods.

[5]  G. Kahaly,et al.  Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves’ Orbitopathy , 2021, Frontiers in Endocrinology.

[6]  P. D. Olivo,et al.  TSH RECEPTOR ANTIBODIES: RELEVANCE & UTILITY. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  P. D. Olivo,et al.  Prospective Trial of Functional Thyrotropin Receptor Antibodies in Graves Disease , 2019, The Journal of clinical endocrinology and metabolism.

[8]  Alexander Seifert,et al.  Human serum albumin presents isoform variants with altered neonatal Fc receptor interactions , 2019, Protein science : a publication of the Protein Society.

[9]  J. Andersen,et al.  The Neonatal Fc Receptor (FcRn): A Misnomer? , 2019, Front. Immunol..

[10]  P. D. Olivo,et al.  High Titers of Thyrotropin Receptor Antibodies Are Associated With Orbitopathy in Patients With Graves Disease. , 2019, The Journal of clinical endocrinology and metabolism.

[11]  G. Kahaly,et al.  Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications. , 2018, Ophthalmic plastic and reconstructive surgery.

[12]  P. D. Olivo,et al.  Prevalence and clinical relevance of thyroid stimulating hormone receptor‐blocking antibodies in autoimmune thyroid disease , 2017, Clinical and experimental immunology.

[13]  Michael B. Otteneder,et al.  Distribution of FcRn Across Species and Tissues , 2017, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  G. Kahaly,et al.  TSH Receptor Antibody Functionality and Nomenclature , 2017, Front. Endocrinol..

[15]  J. Gilquin,et al.  Graves' Disease. , 2017, The New England journal of medicine.

[16]  G. Kahaly,et al.  Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies , 2016, Journal of Endocrinological Investigation.

[17]  F. Szoka,et al.  The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy. , 2015, Advanced drug delivery reviews.

[18]  W. Lencer,et al.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin , 2015, The Journal of Immunology.

[19]  P. D. Olivo,et al.  Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies. , 2015, Thyroid : official journal of the American Thyroid Association.

[20]  M. Segni,et al.  Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. , 2014, The Journal of clinical endocrinology and metabolism.

[21]  N. Pfeiffer,et al.  Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy. , 2011, Ophthalmology.

[22]  G. Kahaly,et al.  A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy. , 2010, The Journal of clinical endocrinology and metabolism.

[23]  R. Latif,et al.  TSH receptor autoantibodies. , 2009, Autoimmunity reviews.

[24]  Frank Fan,et al.  Engineered luciferases for molecular sensing in living cells. , 2009, Current opinion in biotechnology.

[25]  A. Shaw,et al.  Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism1 , 2007, The Journal of Immunology.

[26]  Emiko Mizoguchi,et al.  MHC Class I-Related Neonatal Fc Receptor for IgG Is Functionally Expressed in Monocytes, Intestinal Macrophages, and Dendritic Cells1 , 2001, The Journal of Immunology.

[27]  R. Junghans.  IgG biosynthesis: no "immunoregulatory feedback". , 1997, Blood.

[28]  Pamela J. Bjorkman,et al.  Crystal structure of the complex of rat neonatal Fc receptor with Fc , 1994, Nature.

[29]  M. Zakarija.  The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity. , 1980, Hormone research.